Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 5, 2016, Pages 1375-1380

  Harouaka, Djamila ^a   Engle, Ronald E ^a   Wollenberg, Kurt ^a   Diaz, Giacomo ^b   Tice, Ashley B ^a   Zamboni, Fausto ^c   Govindarajan, Sugantha ^d   Alter, Harvey ^e   Kleiner, David E ^f   Farci, Patrizia ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c BROTZU HOSPITAL   (Italy)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HCV quasispecies; HCV RNA levels; Hepatitis C virus; Hepatocellular carcinoma; Liver

Indexed keywords

MICRORNA 122; VIRUS RNA;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC DISTANCE; GENETIC VARIABILITY; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; VIRAL COMPARTMENTALIZATION; VIRAL PHENOMENA AND FUNCTIONS; VIRUS REPLICATION; GENETICS; HEPACIVIRUS; LIVER TUMOR; PHYSIOLOGY; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HUMANS; LIVER NEOPLASMS; RNA, VIRAL; VIRUS REPLICATION;

EID: 84956654680     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1516879113     Document Type: Article

References (58)

1. Lemon SM, Walker C, Alter MJ, Yi MK (2007) Hepatitis C viruses. Fields Virology, eds Knipe D, Howley P (Lippincott Williams & Wilkins, Philadelphia), 5th Ed
2. Martell M, et al. (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 66(5):3225-3229
3. Farci P (2011) New insights into the HCV quasispecies and compartmentalization. Semin Liver Dis 31(4):356-374
4. Farci P, et al. (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288(5464):339-344
5. Farci P, et al. (2012) Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. Proc Natl Acad Sci USA 109(36):14562-14567
6. Alter HJ, Seeff LB (2000) Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome. Semin Liver Dis 20(1):17-35
7. El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365(12):1118-1127
8. Centers for Disease Control and Prevention (2010) Hepatocellular carcinoma- United States, 2001-2006. MMWR Morb Mortal Wkly Rep 59(17):517-520
9. Saito I, et al. (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87(17):6547-6549
10. McGivern DR, Lemon SM (2011) Virus-specific mechanisms of carcinogenesis in hepatitis C virus-associated liver cancer. Oncogene 30(17):1969-1983
11. Read SA, Douglas MW (2014) Virus-induced inflammation and cancer development. Cancer Lett 345(2):174-181
12. Arvanitakis L, Yaseen N, Sharma S (1995) Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J Immunol 155(3):1047-1056
13. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6):1129-1136
14. Sheahan TP, Rice CM (2013) Single cell analysis of HCV-infected patient hepatocytes: The science is no longer science fiction. Gastroenterology 145(6):1199-1202
15. Gerber MA, et al. (1992) Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol 141(6):1271-1277
16. Haruna Y, et al. (1994) Expression of hepatitis C virus in hepatocellular carcinoma. Cancer 73(9):2253-2258
17. Kobayashi S, Hayashi H, Itoh Y, Asano T, Isono K (1994) Detection of minus-strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma. Cancer 73(1):48-52
18. Dash S, et al. (2000) HCV RNA levels in hepatocellular carcinomas and adjacent nontumorous livers. J Virol Methods 90(1):15-23
19. Horiike N, et al. (1993) Hepatitis C virus plus- and minus-strand RNA in hepatocellular carcinoma and adjoining nontumorous liver. J Med Virol 41(4):312-315
20. Sobesky R, et al. (2007) Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 46(6):1704-1712
21. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309(5740):1577-1581
22. Masaki T, et al. (2015) miR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation. Cell Host Microbe 17(2):217-228
23. Gramantieri L, et al. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67(13):6092-6099
24. Kutay H, et al. (2006) Down-regulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99(3):671-678
25. Murakami Y, et al. (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25(17):2537-2545
26. Spaniel C, et al. (2013) microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection. PLoS One 8(10):e76867
27. Karakatsanis A, et al. (2013) Expression of microRNAs, miR-21, miR-31, miR-122, miR- 145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 52(4):297-303
28. Rüster B, et al. (2001) Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue. J Med Virol 63(2):128-134
29. Saito S, et al. (1996) Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma. Int J Cancer 67(2):199-203
30. Young KC, et al. (2002) Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver. J Med Virol 68(2):188-196
31. Lanford RE, et al. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962):198-201
32. Mantel N (1967) The detection of disease clustering and a generalized regression approach. Cancer Res 27(2):209-220
33. Gosálvez J, et al. (1998) Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis. Hepatology 27(5):1428-1434
34. Lau GK, et al. (1996) Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: A study by in situ reverse-transcription polymerase chain reaction. Hepatology 23(6):1318-1323
35. Liang Y, et al. (2009) Visualizing hepatitis C virus infections in human liver by twophoton microscopy. Gastroenterology 137(4):1448-1458
36. Kandathil AJ, et al. (2013) Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. Gastroenterology 145(6):1404-1413
37. Stiffler JD, et al. (2009) Focal distribution of hepatitis C virus RNA in infected livers. PLoS One 4(8):e6661
38. Hasui T, Shimomura H, Tsuji H, WatoM, Tsuji T (1994) Quantitation of hepatitis C virus RNA in liver tissue as a predictive marker of the response to interferon therapy in chronic hepatitis C. Acta Med Okayama 48(3):151-157
39. Idrovo V, et al. (1996) Hepatitis C virus RNA quantification in right and left lobes of the liver in patients with chronic hepatitis C. J Viral Hepat 3(5):239-246
40. Terrault NA, et al. (1997) Hepatitis C virus: Quantitation and distribution in liver. J Med Virol 51(3):217-224
41. Rüster B, Zeuzem S, Roth WK (1996) Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun 219(3):911-915
42. Schramm F, et al. (2008) Frequent compartmentalization of hepatitis C virus with leukocyterelated amino acids in the setting of liver transplantation. J Infect Dis 198(11):1656-1666
43. Zehender G, et al. (2005) Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J Virol 79(14):9145-9156
44. Fishman SL, et al. (2008) Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis 197(4):597-607
45. Ishak K, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696-699
46. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7(3):462-503
47. Ekholm M, et al. (2014) Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: A comparison of prognostic value and reproducibility. Histopathology 65(2):252-260
48. Engle RE, Russell RS, Purcell RH, Bukh J (2008) Development of a TaqMan assay for the sixmajor genotypes of hepatitis C virus: Comparison with commercial assays. J Med Virol 80(1):72-79
49. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positionspecific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673-4680
50. Hamming WR (1986) Coding and Information Theory (Prentice-Hall, Englewood Cliffs, NJ), 2nd Ed
51. Schwartz RM, Dayhoff MO (1978) Matrices for detecting distant relationships. Atlas of Protein Sequence and Structure, ed Dayhoff MO (National Biomedical Research Foundation, Washington, DC), 3rd Ed, Vol 5, pp 353-358
52. Tamura K, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28(10):2731-2739
53. Dray S, Dufour AB (2007) The ade4 package: Implementing the duality diagram for ecologists. J Stat Softw 22(4):1-20
54. Muse SV, Gaut BS (1994) A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome. Mol Biol Evol 11(5):715-724
55. Felsenstein J (1981) Evolutionary trees from DNA sequences: A maximum likelihood approach. J Mol Evol 17(6):368-376
56. Saitou N, Nei M (1987) The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4(4):406-425
57. Kosakovsky Pond SL, Frost SD (2005) Not so different after all: A comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 22(5):1208-1222
58. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30(12):2725-2729